APOE and cancer: The results suggest a pivotal role of non-sex-specific cancer as a nonlinear modulator of survival in this sample of women that increased the risk of death of the ApoE4 carriers by 150% (p = 5.3×10−8) compared to the non-carriers and explained the 4.2 year differential in life expectancy in this group.